CARBOGEN AMCIS, a Dishman Carbogen Amcis Company, is a global development and manufacturing partner for complex medicines. Specialisms include high-potency APIs, linker and payload chemistry, precise bioconjugation for ADCs and clinical-to-commercial sterile fill-finish. Integrated analytics and CMC/regulatory capabilities reduce handoffs and accelerate timelines, while flow-enabled process design and engineered containment enhance control, throughput and safety at scale. Facilities across Europe and Asia support development, clinical supply and commercial manufacture.
The collaboration combines Celonic’s biologics expertise with Carbogen Amcis’s payload and conjugation capabilities to create a seamless, end-to-end ADC development pathway.